Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

XBIO 015

Next Previous
Drug Profile

XBIO 015

Alternative Names: XBIO-015

Latest Information Update: 11 Aug 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Xenetic Biosciences
  • Class Antineoplastics; Endodeoxyribonucleases; Recombinant proteins
  • Mechanism of Action Extracellular trap inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Pancreatic cancer
  • Preclinical Colorectal cancer; Solid tumours

Most Recent Events

  • 30 Jul 2025 Xenetic Biosciences enters into a clinical trial agreement" with PeriNess Ltd to support the exploratory clinical trial in B-cell lymphoma
  • 30 Jul 2025 Xenetic Biosciences in collaboration with PeriNess plans a clinical trial for large B cell lymphoma
  • 08 Jul 2025 Phase-I trials in Pancreatic cancer (Adjunctive treatment, First-line therapy, Late-stage disease, Metastatic disease, Inoperable/Unresectable) in Israel (IV)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top